June 29 (Reuters) - BioScrip Inc ::BioScrip announces new senior note facilities.BioScrip Inc - under agreement, company entered into a $200 million first lien note facility and a $110 million second lien note facility.BioScrip Inc - to use proceeds of facilities to repay in full all amounts outstanding under its previous senior credit facilities and its priming credit agreement.BioScrip Inc - also as part of agreement, will receive a $16 million common stock investment, and will issue common stock warrants with a 10-year term..
June 28 (Reuters) - Fortis Healthcare Ltd ::Gets members' nod to increase in shareholding limit for FIIs to aggregate limit of 74 percent of paid up equity share capital of co.
June 14 (Reuters) - LIFEWATCH AG :EQS-ADHOC: LIFEWATCH AG: BIOTELEMETRY PUBLISHES THE DEFINITIVE NOTICE OF THE INTERIM RESULT.BIOTELEMETRY ( OFFEROR) CONFIRMED TODAY THAT SHAREHOLDERS TENDERED APPROXIMATELY 83 PERCENT OF OUTSTANDING TOTAL SHARES OF LIFEWATCH AG DURING TENDER PERIOD AND DECLARED OFFER TO BE SUCCESSFUL.ADDITIONAL ACCEPTANCE PERIOD OF 10 TRADING DAYS FOR SUBSEQUENT ACCEPTANCE OF OFFER WILL START ON JUNE 15, 2017, AND IS EXPECTED TO RUN UNTIL JUNE 28, 2017, 4.00 P.M. CET.
May 31 (Reuters) - ESPERITE NV ::HAS CONCLUDED NEW AGREEMENTS WITH ITS NOTE HOLDERS.EDUCE CAPITAL AND FREDERIC AMAR, HAVE AGREED THEIR NOTES, FOR A TOTAL AMOUNT OF EUR 3'125'000, TO BE REPAID BY ISSUANCE OF NEW UNSECURED CONVERTIBLE LOANS.NEW NOTES WILL MATURE ON 31 DECEMBER 2019, UNLESS EARLIER CONVERTED OR REPURCHASED, THEY WILL NOT BE LISTED AND ARE SUBJECT TO SHAREHOLDERS APPROVAL.BOARD HAS ON MAY 26, 2017 PROPOSES AND NEGOTIATES POSSIBLE ISSUANCE OF NEW NOTES TO REPAY NOTE HOLDERS.NEW NOTES CONVERTIBLE INTO ESPERITE SHARES ACCORDING TO INITIAL SCHEDULE OF PREVIOUS NOTES, UNTIL MATURITY AT AN INITIAL CONVERSION PRICE OF EUR 0.45.NEW UNSECURED CONVERTIBLE LOAN NOTES WILL BEAR INTEREST AT A RATE OF 7% PER YEAR, PAYABLE ANNUALLY IN ARREARS ON 31 DECEMBER.
May 19 (Reuters) - Winning Health Technology Group Co Ltd <300253.SZ> ::* Says it will pay cash dividend of 0.65 yuan(before tax)/10 shares and use additional paid in capital to distribute 9 new shares for every 10 shares for 2016 to shareholders of record on May 24.* The company's shares will be traded ex-right and ex-dividend on May 25 and the dividend will be paid on May 25.
May 12 (Reuters) - Aier Eye Hospital Group Co Ltd <300015.SZ> ::* Says it will pay cash dividend of 1.8 yuan(before tax)/10 shares and use additional paid-in capital to distribute 5 new shares for every 10 shares for 2016 to shareholders of record on May 17.* The company's shares will be traded ex-right and ex-dividend on May 18 and the dividend will be paid on May 18 .
April 24 (Reuters) - Healthway Medical Corp Ltd ::SGX-ST has no objection to grant 3 months extension of time for company to hold its annual general meeting.SGX-ST has no objection to grant 3 months extension of time for co to release its unaudited financial statements for q1.Delay in AGM as co awaits outcome of meeting related to acquisition of Healthway Medical Enterprise & issuance of convertible notes.
Micro-X Ltd : Entitlement offer will open on , 20 april 2017 and closes at 5:00pm on 2 may 2017, and is expected to raise up to about $4.8 million .Entitlement at issue price of $0.40 per new share.
London-listed Russian healthcare provider MD Medical Group Investments Plc : Says that its shareholders on April 28 will vote on the issue of up to 8.4 million ordinary shares of US$0.08 each . The board would be authorised to allot and issue up to 8.4 million shares until April 27, 2022 . The company can make use of this decision within next five years, now "it does not oblige to anything", IR director Elena Romanova told Reuters . The company has a large number of projects that were announced as part of the development strategy and will be implemented until 2021. If the implementation of the projects requires additional financing, and there will be favorable market conditions and a fair price for shares, "we do not exclude the possibility of holding an SPO", she said . The market was expecting the SPO in the spring window, but it did not take place [nL8N1G06IC] .MD Medical head Mark Kurtser had said his company is considering SPO in principle, but during a conference call on 2016 results he said there are no plans for the placement in the nearest future.
MD Medical Group Investments Plc : Says that its shareholders on April 28 will vote on the issue of up to 8.4 million ordinary shares of US$0.08 each .The board would be authorised to allot and issue up to 8.4 million shares until April 27, 2022.